Truncated L1 protein of human papillomavirus type 6
US8748127B2 · kind B2 · utility
1Cited by
6References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2008 |
| Grant date | Jun 10, 2014 |
| Priority date | — |
| Expiry date | May 29, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a truncated L1 protein of the Human Papillomavirus Type 6, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.